ThursdayApr 16, 2026 10:00 am

New AI Tool Could Boost the Early Detection of Lung Cancer

Lung cancer is the leading cause of cancer-linked fatalities among men and women, and survival beyond five years post-diagnosis is minimal. This is largely because most cases are detected when they are already advanced. Scientists are therefore searching for ways to boost early detection so that treatment outcomes can improve and survival can increase.  A new study seems to have found a way to use AI to improve the early detection of this disease. This tool could be especially helpful in flagging lung cancer when tumors are still small and are harder to detect using the existing diagnostic tools.  These existing tools, such as CT scans, have…

Continue Reading

TuesdayApr 14, 2026 10:00 am

Preclinical Study Reveals Promising Treatment for Glioblastoma

Glioblastoma is a deadly type of brain cancer which progresses rapidly and kills victims within months. For nearly two decades, no significant progress has been made in developing an effective treatment against this malignancy. Now, a new preclinical study using animal models has unveiled a potential breakthrough that could eliminate these tumors.  The study, whose findings were published in the journal Nature, was conducted by scientists at the startup Trogenix. The team is made up of scientists at the Cancer Institute at University College London, the Royal Infirmary at Edinburgh, and the University of Edinburgh.  The team developed SSEs technology (Synthetic Super-Enhancers) that entails using a viral vector to carry genetic instructions into glioblastoma tumors. The genetic instructions…

Continue Reading

FridayApr 10, 2026 10:00 am

Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA

The immune system is capable of identifying and attacking cancer cells in the body. This process depends on the tumor producing damaged RNA, which then sticks to cell surfaces and provides the antigens that the body identifies as foreign and therefore targets. However, a natural mechanism within the body that removes faulty RNA ironically aids many cancers to avoid detection and therefore limit immune system responses to the disease.  Now, a new preclinical study has found that targeting and blocking this clean-up mechanism can allow cancer antigens to express on tumor cells and allow the immune system to quickly identify and attack them.  The study was conducted by a University…

Continue Reading

ThursdayApr 09, 2026 10:00 am

Shares of Health Insurers Rally After CMS Bumps Up 2027 Rates

The shares of health insurers in the U.S. recorded gains after the Trump administration announced 2027 payment rate increases for Medicare Advantage that were higher than what had been proposed back in January. That improved rate would increase payments to these firms by about $13bn in the coming fiscal year 2027.  In January when the federal government revealed that it would be increasing these payments by 0.09%, the insurance firms took a hit to their stock prices because this rate was much lower than had been expected. Investors viewed that small increase as additional pressure on already tight margins, but the surprise announcement of about 2.8% extra payments to MA firms covering older…

Continue Reading

TuesdayApr 07, 2026 10:00 am

Study Explores Whether a Common Vitamin Could Fight Brain Cancer

Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds promise in restoring immune function in the fight against glioblastoma, a brain cancer that grows aggressively and is hard to treat.  For over two decades, no significant advancement has been made to improve treatment outcomes in patients with glioblastoma. Treatments like radiation, surgery and chemotherapy help, but the tumors regrow and survival times are dismal. The team at the University of Calgary wanted to establish whether vitamin B3 in high doses may boost treatment outcomes when used alongside current treatment approaches.  The scientists want to find out whether this…

Continue Reading

MondayApr 06, 2026 10:00 am

Gallup Poll: Healthcare Returns to the Top of Americans’ Biggest Domestic Worries

According to a poll conducted by Gallup in March, Americans are most concerned about healthcare. This finding is notable given the escalation in the Iran war and the way events in the Middle East are currently dominating news headlines.  Gallup conducted a poll seeking the views of Americans about how much they worry about a list of 15 policy areas on the domestic front. 61% of the respondents revealed that they are greatly worried about healthcare. The next four biggest sources of worry for Americans were connected to economic issues.  Those policy issues are the state of the economy, concerns about inflation in the country, spending by…

Continue Reading

TuesdayMar 31, 2026 10:00 am

Researchers Discover Mechanism Behind Deadly Pediatric Brain Cancer

A team of scientists from Texas Children’s Hospital, University of Pittsburgh and Baylor College of Medicine has discovered the primary driver of a deadly pediatric brain cancer, PFA (posterior fossa type A) ependymoma. They identified male sex hormones called androgens as playing a key role in promoting PFA ependymoma growth.  The study, whose findings appeared in the journal Nature, shows that androgens don’t play a part in the development of any other kind of brain tumor.  The team’s work shows that when the signaling of these hormones is blocked, the growth of the tumors is blocked. This discovery creates a possibility that treatments could be developed to block these hormones to…

Continue Reading

ThursdayMar 26, 2026 10:00 am

Hackers Linked to Iran Target Another US Health Care Institution

On Tuesday this week, researchers revealed that a group of hackers linked to the Iranian government had targeted another United States medical institution toward the end of February prior to the onset of the current military conflict between the U.S., Israel and Iran. This is the second such attack.  This attack is noteworthy because this information comes on the heels of another attack in which Stryker, a medical device firm in America, was targeted and had its data deleted. Handala, a hacktivist group linked to Iran, claimed responsibility for this attack that resulted in about 80,000 systems being deleted. Stryker is currently restoring its systems and the attack has now been contained.  It isn’t clear whether other attacks have happened…

Continue Reading

TuesdayMar 24, 2026 10:00 am

Misinformation Could Thwart the Potential of Cancer Vaccines

For a long time, scientists have been working tirelessly to come up with vaccines against cancer. Significant progress is being registered in developing mRNA vaccines against cancer, but this progress has come up against a wall of misinformation that could thwart the prospects of this promising intervention.  Most people first heard about mRNA vaccines during the Covid-19 pandemic when these vaccines were widely used to bring the pandemic under control. However, misinformation soon spread that these vaccines were not only accelerating cancer rates but also causing cancer to be “turbo-charged.” Social media was awash with stories of “turbo cancer” starting in 2021 and mainstream media caught…

Continue Reading

FridayMar 20, 2026 10:00 am

Oncolytic Virus Therapy is Set to Transform Cancer Care

Enormous resources are being channeled into studying different ways to support the immune system in its fight against cancer. One emerging approach is the use of oncolytic viruses. This approach seeks to leverage viruses to destroy cancer by attacking and killing its cells.  The approach stems from the discovery that a number of cancers are linked to viral infections, such as HPV, which has been linked to the development of head and neck cancer, as well as cervical cancer. Liver cancer has also been linked to the hepatitis B virus. A number of vaccines have been developed to prevent some of these cancers by preventing infection by these viruses.  Scientists are now looking to go a step further by…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000